|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2001-8-15
|
|
pubmed:abstractText |
Therapy with a HIV protease inhibitor is associated with elevations in cholesterol and triglycerides. HMG-CoA reductase inhibitors ('statins') are the established therapy for persons with primary hypercholesterolaemia. Because of drug interactions, pravastatin may represent the preferred choice in those taking HIV protease inhibitors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
17
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1503-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11504982-Anticholesteremic Agents,
pubmed-meshheading:11504982-Cholesterol, LDL,
pubmed-meshheading:11504982-Combined Modality Therapy,
pubmed-meshheading:11504982-HIV Infections,
pubmed-meshheading:11504982-HIV Protease Inhibitors,
pubmed-meshheading:11504982-HIV-1,
pubmed-meshheading:11504982-Humans,
pubmed-meshheading:11504982-Hypercholesterolemia,
pubmed-meshheading:11504982-Male,
pubmed-meshheading:11504982-Pravastatin,
pubmed-meshheading:11504982-Viral Load
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy.
|
|
pubmed:affiliation |
Chelsea and Westminster Hospital, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
